<SEC-DOCUMENT>0001176256-16-000421-index.html : 20160209 <SEC-HEADER>0001176256-16-000421.hdr.sgml : 20160209 <ACCEPTANCE-DATETIME>20160209131849 ACCESSION NUMBER: 0001176256-16-000421 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20160209 FILED AS OF DATE: 20160209 DATE AS OF CHANGE: 20160209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 161398446 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>nymox6kprosssuppl160209.htm <DESCRIPTION>REPORT OF FOREIGN ISSUER FOR THE MONTH OF FEBRUARY, 2016 <TEXT> Document 1 - file: nymox6kprosssuppl160209.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>exhibit99-1.htm <DESCRIPTION>PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5) <TEXT> Document 2 - file: exhibit99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>exhibit99-1x1x1.jpg <TEXT> Document 3 - file: exhibit99-1x1x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>exhibit99-1x13x1.jpg <TEXT> Document 4 - file: exhibit99-1x13x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>exhibit99-1x48x1.jpg <TEXT> Document 5 - file: exhibit99-1x48x1.jpg
</DOCUMENT> </SEC-DOCUMENT>